Which Surgery for Stage II-III Empyema Patients? Observational Single-Center Cohort Study of 719 Consecutive Patients.

Sara Ricciardi Delia GiovannielloFrancesco CarleoMarco Di MartinoMassimo O JausSara MantovaniStefano TreggiariLuigi TritapepeGiuseppe Cardillo

Published in: Journal of clinical medicine (2022)

Our findings suggest that the VATS approach, showing a 99% success rate, shorter length of stay and lower postoperative morbidity, should be considered the treatment of choice for thoracic empyema.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
minimally invasive
spinal cord
patient reported outcomes
percutaneous coronary intervention
coronary artery bypass
combination therapy
replacement therapy